Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Uttam Satyal"'
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
With recent advancements in a non-invasive approach to cancer diagnosis and surveillance, the term “liquid biopsy” has gained traction but is currently limited by technological challenges in identifying and isolating circulating tumor cells (CTCs
Externí odkaz:
https://doaj.org/article/8734a210a5d4424da77f557711a70101
Publikováno v:
Bladder Cancer. 6:471-479
BACKGROUND: Bladder cancer is one of the most common types of cancer diagnosed each year, and more than half of patients have non-muscle invasive bladder cancer (NMIBC). The standard of care for patients with high-grade NMIBC is Bacillus Calmette-Gue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74cb5b865e54215fc7d872ee590048d4
https://doi.org/10.3233/blc-200340
https://doi.org/10.3233/blc-200340
Publikováno v:
Curr Opin Urol
Purpose of review The purpose of this review is to examine and evaluate similarities and differences in bladder cancer expression subtypes and to understand the clinical implications of the molecular subtyping. Recent findings Four independent classi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::813172f2726e776c695a81f2a0e73321
https://doi.org/10.1097/mou.0000000000000641
https://doi.org/10.1097/mou.0000000000000641
Autor:
Uttam Satyal, David Weader, Henkel Valentine, Michael Stromyer, Wiley J. Youngs, Philip H. Abbosh
Publikováno v:
Cancer Research. 82:4058-4058
Introduction: Intravesical therapy is critical in management of high-risk non-muscle invasive bladder cancer. The most effective intravesical therapy, BCG, has an ongoing shortage, while other second line therapies are not very effective, leaving rad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0ddc435bb80d92f7d4a840c65a8a07fd
https://doi.org/10.1158/1538-7445.am2022-4058
https://doi.org/10.1158/1538-7445.am2022-4058
Publikováno v:
Cancer Research. 82:942-942
Introduction: In forward genetics, a phenotype (sensitivity to therapy) is attributed to a genotype (mutation in relevant gene) based on findings in anecdotal cases (e.g., extreme responders) with little systematic/experimental study. Although powerf
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e44690b225dfc07345ea733e6628fc9b
https://doi.org/10.1158/1538-7445.am2022-942
https://doi.org/10.1158/1538-7445.am2022-942
Autor:
Philip Abbosh, Rashida Ginwala, Abhishek Srivastava, Uttam Satyal, Jodie Franklin, James R. White
Publikováno v:
Cancer Research. 81:2912-2912
Background: BBN (N-butyl-N-(4-hydroxybuytl) nitrosamine) is the most commonly employed carcinogen in the classical animal model of bladder cancer based on chemical carcinogenesis of the bladder urothelium. BBN closely recapitulates the histological a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ebddc93146d980589fedd5f0c80c9532
https://doi.org/10.1158/1538-7445.am2021-2912
https://doi.org/10.1158/1538-7445.am2021-2912
Autor:
Eliezer M. Van Allen, Eduoard Trabulsi, Philip Abbosh, Costas D. Lallas, Uttam Satyal, Alexander Kutikov, Michael Slifker, Kent W. Mouw, Paul Cairns, David Liu, Ilsiya Ibragimova, Elizabeth R. Plimack, Jean H. Hoffman-Censits, R. K. Alpaugh
Publikováno v:
Cancer Research. 81:548-548
Introduction: Neoadjuvant chemotherapy results in 30-40% complete response rates in patients undergoing radical cystectomy (RC) for bladder cancer. There is significant interest in identifying complete responders prior to RC in order to potentially a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9c272c38ca0818c0ca02adf470efa873
https://doi.org/10.1158/1538-7445.am2021-548
https://doi.org/10.1158/1538-7445.am2021-548
Autor:
Marc A. Ilies, Bogdan Draghici, Muniswamy Madesh, Qiangnan Zhang, Kyle W. Norris, Lisa Dragic, Eugen Brailoiu, Uttam Satyal
Publikováno v:
ACS Appl Mater Interfaces
This article presents the synthesis, self-assembly, and biological activity as transfection agents for pDNA, siRNA, and mRNA of novel pyridinium pseudogemini surfactants, interfacially engineered from the most efficient gemini surfactants and lipids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::829251781ee8d83c97057a5cb5f90067
https://doi.org/10.1021/acsami.7b07066
https://doi.org/10.1021/acsami.7b07066
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology, Vol 9 (2019)
With recent advancements in a non-invasive approach to cancer diagnosis and surveillance, the term "liquid biopsy" has gained traction but is currently limited by technological challenges in identifying and isolating circulating tumor cells (CTCs), p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c6387cdc5fbd0f20d08fb402fb61dfc
https://pubmed.ncbi.nlm.nih.gov/31803629
https://pubmed.ncbi.nlm.nih.gov/31803629
Autor:
David J. Weader, Marie R. Southerland, Wiley J. Youngs, Michael L. Stromyer, Abhishek Srivastava, Uttam Satyal, Philip Abbosh
Publikováno v:
Cancer Research. 80:6366-6366
Introduction: Intravesical therapy has critical role in the treatment of high-risk non-muscle invasive bladder cancer. Due to ongoing shortage of BCG and lack of effective alternatives, there is an urgent need for novel intravesical chemotherapeutic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74538ec0ce3c828ea35db76940784e0a
https://doi.org/10.1158/1538-7445.am2020-6366
https://doi.org/10.1158/1538-7445.am2020-6366